Malignancy in Noonan syndrome and related disorders

Clinical Genetics

Volumn 88, Issue 6, 2015, Pages 516-522

  Smpokou, P ^a,b   Zand, D J ^a,b   Rosenbaum, K N ^a,b   Summar, M L ^a,b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Cardiofaciocutaneous syndrome; Costello syndrome; LEOPARD syndrome; Malignancy; Noonan syndrome; Noonan syndrome with multiple lentigines; Ras MAPK pathway; RASopathy; Tumor

Indexed keywords

PROTEIN TYROSINE PHOSPHATASE SHP 2; RAS PROTEIN;

CARDIOFACIOCUTANEOUS SYNDROME; CLINICAL FEATURE; COSTELLO SYNDROME; GENE MUTATION; HUMAN; LEOPARD SYNDROME; LEUKEMIA; LYMPHOMA; MOLECULAR PATHOLOGY; NOONAN SYNDROME; PHENOTYPE; PRIORITY JOURNAL; REVIEW; BIOLOGICAL MODEL; GENETIC PREDISPOSITION; GENETICS; MUTATION; RISK FACTOR; SIGNAL TRANSDUCTION;

COSTELLO SYNDROME; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEOPARD SYNDROME; MAP KINASE SIGNALING SYSTEM; MODELS, GENETIC; MUTATION; NOONAN SYNDROME; RAS PROTEINS; RISK FACTORS;

EID: 84946499767     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/cge.12568     Document Type: Review

References (60)

1. Tartaglia M, Gelb BD, Zenker M. Noonan syndrome and clinically related disorders. Best Pract Res Clin Endocrinol Metab 2011: 25 (1): 161-179.
2. Bos JL. Ras oncogenes in human cancer: a review. Cancer Res 1989: 49: 4682-4689.
3. Tartaglia M, Martinelli S, Stella L et al. Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease. Am J Hum Genet 2006: 78: 279-290.
4. Tartaglia M, Mehler E, Goldberg R et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP2, cause Noonan syndrome. Nat Genet 2001: 29: 465-468.
5. Roberts A, Araki T, Swanson K et al. Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat Genet 2007: 39: 70-74.
6. Schubbert S, Zenker M, Rowe SL et al. Germline KRAS mutations cause Noonan syndrome. Nat Genet 2006: 38 (3): 331-336.
7. Cirstea IC, Kutsche K, Dvorsky R et al. A restricted spectrum of NRAS mutations causes Noonan syndrome. Nat Genet 2010: 42 (1): 27-29.
8. Pandit B, Sarkozy A, Pennachio L et al. Gain of function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet 2007: 39: 1007-1012.
9. Cordeddu V, Schiavi E, Pennachio LA et al. Mutation of SHOC2 promotes aberrant N-myristoylation and causes Noonan-like syndrome with loose anagen hair. Nat Genet 2009: 41: 1022-1026.
10. Martinelli S, De Luca A, Stellacci E et al. Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome- like phenotype. Am J Hum Genet 2010: 87: 250-257.
11. Aoki Y, Niihori T, Banjo T et al. Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome. Am J Hum Genet 2013: 93: 173-180.
12. Chen P-C, Yin J, Yu H-W et al. Next-generation sequencing identifies rare variants associated with Noonan syndrome. Proc Natl Acad Sci USA 2014: 111 (31): 11473-11478.
13. Roberts AE, Allanson JE, Tartaglia M, Gelb BD. Noonan syndrome. Lancet 2013: 381: 333-342.
14. Martinez-Quintana E, Rodríguez-González F. LEOPARD syndrome: clinical features and gene mutations. Mol Syndromol 2012: 3: 145-157.
15. Sarkozy A, Carta C, Moretti S et al. Germline BRAF mutations in Noonan, LEOPARD and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum. Hum Mutat 2009: 30 (4): 695-702.
16. Rodriguez-Viciana P, Tetsu O, Tidyman WE et al. Germline mutations in genes within the MAPK pathway cause cardiofaciocutaneous syndrome. Science 2006: 311 (5765): 1287-1290.
17. Nava C, Hanna N, Michot C et al. Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signaling pathway: genotype-phenotype relationships and overlap with Costello syndrome. J Med Genet 2007: 44 (12): 763-771.
18. Allanson JE, Annerén G, Aoki Y et al. CFC syndrome: does genotype predict phenotype. Am J Med Genet C Semin Med Genet 2011: 157C (2): 129-135.
19. Gripp KW. Tumor predisposition in Costello syndrome. Am J Med Genet C Semin Med Genet 2005: 137C: 72-77.
20. Chantrain CF, Jijon P, De Raedt T et al. Therapy-related acute myeloid leukemia in a child with Noonan syndrome and clonal duplication of the germline PTPN11 mutation. Pediatr Blood Cancer 2007: 48: 101-104.
21. Matsubara K, Yabe H, Ogata T, Yoshida R, Fukaya T. Acute myeloid leukemia in an adult Noonan syndrome patient with PTPN11 mutation. Am J Hematol 2005: 79: 171-173.
22. Sakamoto K, Imamura T, Asai D et al. Acute lymphoblastic leukemia developing in a patient with Noonan syndrome harboring a PTPN11 germline mutation. J Pediatr Hematol Oncol 2014: 36 (2): e136-e139.
23. Piombo M, Rosanda C, Pasino M, Marasini M, Cerruti P, Comelli A. Acute lymphoblastic leukemia in Noonan syndrome: report of two cases. Med Pediatr Oncol 1993: 21: 454-455.
24. Attard-Montalto SP, Kingston JE, Eden T. Noonan syndrome and acute lymphoblastic leukemia. Med Pediatr Oncol 1994: 23: 391-392.
25. Johannes JM, Garcia ER, De Vaan GA, Weening RS. Noonan's syndrome in association with acute leukemia. Pediatr Hematol Oncol 1995: 12: 571-575.
26. Karow A, Steinemann D, Göhring G et al. Clonal duplication of a germline PTPN11 mutation due to acquired uniparental disomy in acute lymphoblastic leukemia blasts from a patient with Noonan syndrome. Leukemia 2007: 21 (6): 1303-1305.
27. Roti G, La Starza R, Ballanti S et al. Acute lymphoblastic leukaemia in Noonan syndrome. Br J Haematol 2006: 133 (4): 448-450.
28. Pauli S, Steinemann D, Dittmann K et al. Occurrence of acute lymphoblastic leukemia and juvenile myelomonocytic leukemia in a patient with Noonan syndrome carrying the germline PTPN11 mutation p.E139D. Am J Med Genet A 2012: 158A (3): 652-658.
29. La Starza R, Rosati R, Roti G et al. A new NDE1/PDGFRB fusion transcript underlying chronic myelomonocytic leukemia in Noonan syndrome. Leukemia 2007: 21: 830-833.
30. Jongmans MJC, Van der Burgt I, Hoogerbrugg PM et al. Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation. Eur J Hum Genet 2011: 19: 870-874.
31. Ferrero GB, Baldassarre G, Delmonaco AG et al. Clinical and molecular characterization of 40 patients with Noonan syndrome. Eur J Med Genet 2008: 51: 566-572.
32. Lo FS, Kuo TT, Wang CJ, Kuo MT, Kuo MC. Hodgkin's lymphoma in a patient with Noonan syndrome with a germline PTPN11 mutation. Int J Hematol 2008: 88: 287-290.
33. Jongmans M, Otten B, Noordam K, Van der Burgt I. Genetics and variation in phenotype in Noonan syndrome. Horm Res 2004: 62 (Suppl. 3): 56-59.
34. Merks JH, Caron HN, Hennekam RC. High incidence of malformation syndromes in a series of 1, 073 children with cancer. Am J Med Genet A 2005: 134A (2): 132-143.
35. Jung A, Bechthold S, Pfluger T, Renner C, Ehrt O. Orbital rhabdomyosarcoma in Noonan syndrome. J Pediatr Hematol Oncol 2003: 25 (4): 330-332.
36. Moschovi M, Touliatou V, Papadopoulou A et al. Rhabdomyosarcoma in a patient with Noonan syndrome phenotype and review of the literature. J Pediatr Hematol Oncol 2007: 29 (5): 341-344.
37. Denayer E, Devriendt K, de Ravel T et al. Tumor spectrum in children with Noonan syndrome and SOS1 or RAF1 mutations. Genes Chromosomes Cancer 2010: 49: 242-252.
38. Jongmans MCJ, Hoogerbrugge PM, Hilkens L et al. Noonan syndrome, the SOS1 gene and embryonal rhabdomyosarcoma. Genes Chromosomes Cancer 2010: 49: 635-641.
39. Khan S, McDowell H, Upadhyaya M, Fryer A. Vaginal rhabdomyosarcoma in a patient with Noonan syndrome. J Med Genet 1995: 32: 743-745.
40. Kondoh T, Ishii E, Aoki Y et al. Noonan syndrome with leukaemoid reaction and overproduction of catecholamines: a case report. Eur J Pediatr 2003: 162: 548-549.
41. Mutesa L, Pierquin G, Janin N et al. Germline PTPN11 missense mutation in a case of Noonan syndrome associated with mediastinal and retroperitoneal neuroblastic tumors. Cancer Genet Cytogenet 2008: 182: 40-42.
42. Bentires-Alj M, Paez JG, David FS et al. Activating mutations of the Noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res 2004: 64: 8816-8820.
43. Fryssira H, Leventopoulos G, Psoni S, Kitsiou-Tzeli S et al. Tumor development in three patients with Noonan syndrome. Eur J Pediatr 2008: 167: 1025-1031.
44. Sherman CB, Ali-Nazir A, Gonzales-Gomez I, Finlay JL, Dhall G. Primary mixed glioneuronal tumor of the central nervous system in a patient with Noonan syndrome. J Pediatr Hematol Oncol 2009: 31 (1): 61-64.
45. Schuettpelz LG, McDonald S, Whitesell K et al. Pilocytic astrocytoma in a child with Noonan syndrome. Pediatr Blood Cancer 2009: 53: 1147-1149.
46. Smpokou P, Tworog-Dube E, Kucherlapati RS, Roberts AE. Medical complications, clinical findings, and educational outcomes in adults with Noonan syndrome. Am J Med Genet A 2012: 158A: 3106-3111.
47. Aggarwal A, Krishnan J, Kwart A, Perry D. Noonan's syndrome and seminoma of undescended testicle. South Med J 2001: 94: 432-434.
48. Yoshida R, Ogata T, Masawa N, Nagai T. Hepatoblastoma in a Noonan syndrome patient with a PTPN11 mutation. Pediatr Blood Cancer 2008: 50: 1274-1276.
49. Keren B, Hadchouel A, Saba S et al. PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience. J Med Genet 2004: 41: e117.
50. Ucar C, Calypkan U, Martini S, Heinritz W. Acute myelomonocytic leukemia in a boy with LEOPARD syndrome (PTPN11 gene mutation positive). J Pediatr Hematol Oncol 2006: 28: 123-125.
51. Laux D, Kratz C, Sauerbrey A. Common acute lymphoblastic leukemia in a girl with genetically confirmed LEOPARD syndrome. J Pediatr Hematol Oncol 2008: 30: 602-604.
52. Rankin J, Short J, Turnpenny P, Castle B, Hanemann CO. Medulloblastoma in a patient with the PTPN11 p.Thr468Met mutation. Am J Med Genet A 2013: 161A: 2027-2029.
53. Choi W-W, Yoo J-Y, Park K-C, Kim K-H. LEOPARD syndrome with a new association of congenital corneal tumor, Choristoma. Pediatr Dermatol 2003: 20 (2): 158-160.
54. Makita Y, Narumi Y, Yoshida M et al. Leukemia in cardio-facio-cutaneous (CFC) syndrome: a patient with a germline mutation in BRAF proto-oncogene. J Pediatr Hematol Oncol 2007: 29: 287-290.
55. Van den Berg H, Hennekam RC. Acute lymphoblastic leukemia in a patient with cardiofaciocutaneous syndrome. J Med Genet 1999: 36: 799-800.
56. Ohtake A, Aoki Y, Saito Y et al. Non-Hodgkin lymphoma in a patient with cardiofaciocutaneous syndrome. J Pediatr Hematol Oncol 2011: 33: e342-e346.
57. Al-Rahawan MM, Chute DJ, Sol-Church K et al. Hepatoblastoma and heart transplantation in a patient with cardio-facio-cutaneous syndrome. Am J Med Genet A 2007: 143A: 1481-1488.
58. Bisogno G, Murgia A, Mammi I, Strafella MS, Carli M. Rhabdomyosarcoma in a patient with cardio-facio-cutaneous syndrome. J Pediatr Hematol Oncol 1999: 21 (5): 424-427.
59. Aoki Y, Niihori T, Narumi Y, Kure S, Matsubara Y. The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders. Hum Mutat 2008: 29 (8): 992-1006.
60. Tidyman WE, Rauen KA. The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. Curr Opin Genet Dev 2009: 19 (3): 230-236.